Mitochondrial calcium uptake is critical for regulating ATP production, intracellular calcium signalling, and cell death. This uptake is mediated by a highly selective calcium channel called the mitochondrial calcium uniporter (MCU). Here, we determined the structures of the pore-forming MCU proteins from two fungi by X-ray crystallography and single-particle cryo-electron microscopy. The stoichiometry, overall architecture, and individual subunit structure differed markedly from those described in the recent nuclear magnetic resonance structure of Caenorhabditis elegans MCU. We observed a dimer-of-dimer architecture across species and chemical environments, which was corroborated by biochemical experiments. Structural analyses and functional characterization uncovered the roles of key residues in the pore. These results reveal a new ion channel architecture, provide insights into calcium coordination, selectivity and conduction, and establish a structural framework for understanding the mechanism of mitochondrial calcium uniporter function.
Mitochondrial Ca
2+ uptake is pivotal for fundamental cellular processes such as ATP production, cell death, and cytosolic Ca 2+ signalling [1] [2] [3] . Rapid mitochondrial Ca 2+ uptake is mediated by an ion channel called the mitochondrial Ca 2+ uniporter [4] [5] [6] . The uniporter resides in the inner mitochondrial membrane, is remarkably selective for Ca 2+ , has high conductance, and is inhibited by ruthenium red 1, 7 . During cytoplasmic Ca 2+ signalling, local increases in the Ca 2+ concentration activate the uniporter 8,9 , leading to substantial Ca 2+ influx. Recent studies identified and established MCU as the essential pore-forming subunit of the Ca 2+ conduction channel [10] [11] [12] [13] . MCU shows higher-order oligomerization 13, 14 and bears no discernible sequence similarity to other known channels. It forms a multicomponent complex with regulatory subunits, including MICU [15] [16] [17] [18] [19] [20] , EMRE 13, 21, 22 , MCUb 23 , and MCUR1 16, 24, 25 . MCU is ubiquitous in plants and metazoans and present in protozoans and fungi 10, 26 . By contrast, EMRE is found only in metazoans and MICU is absent from most fungi 21, 26 . Malfunction or deregulation of the uniporter complex has been linked to tumour progression, muscle weakness, neurological defects, and impairments in tissue regeneration 27 . MCU is characterized by a highly conserved signature DXXE motif, two transmembrane helices, and flanking coiled-coils 26 . Its N-terminal domain (NTD) shows reliable sequence conservation only among metazoan species. This observation raises the question of whether MCU has a unified overall architecture. Recent nuclear magnetic resonance (NMR) studies of a Caenorhabditis elegans MCU (cMCU) core domain provided a first glimpse into the structure of MCU 28 . These investigations defined a pentamer architecture with a layered domain organization and revealed the formation of the inner core by transmembrane helix 2 (TM2) and the pore-facing location of a glutamate residue that is critical for Ca 2+ uptake 28 . However, the cMCU construct neither contained the NTD nor conducted Ca 2+ by itself. Furthermore, without an apparent Ca 2+ permeation route or defined chemistry of the selectivity filter in the NMR structure, the mechanism of Ca 2+ coordination and permeation remains unclear.
Here, we determined the structure of MCU with all structural domains, capable of conducting Ca 2+ . Unexpectedly, our X-ray crystallography and cryo-electron microscopy (cryo-EM) studies revealed a dimer-of-dimer assembly of MCU. Both the overall architecture and the structure of each protomer were distinct from those of the NMR structure of cMCU, giving rise to a completely different pore. Our structures define the key elements of the Ca 2+ permeation pathway and provide insights into Ca 2+ selectivity.
Functional characterization and crystal structure
We identified two MCUs from fungi, Fusarium graminearum MCU (FgMCU) and Metarhizium acridum MCU (MaMCU) (Extended Data Fig. 1a ), that showed excellent biochemical behaviour (Extended Data Fig. 1b, c) . As EMRE is absent in fungi 21 and another fungal MCU was shown to mediate mitochondrial Ca 2+ uptake 29 , these MCUs were potentially sufficient for basic uniporter activity. In an Escherichia coli-based system with the fluorescent Ca 2+ reporter GCaMP2 30 , cells with wild-type MaMCU (Fig. 1a) or FgMCU (Extended Data Fig. 1d ) showed robust Ca 2+ uptake. This uptake was diminished by mutation of residues critical for Ca 2+ conductance 10, 11 or addition of the classic uniporter inhibitor ruthenium red (Fig. 1a , Extended Data Fig. 1d ). Furthermore, when reconstituted in liposomes, purified wild-type MaMCU (Fig. 1b) and FgMCU (Extended Data Fig. 1e ) showed robust ion conduction activity in a fluorescence-based flux assay 31 . The addition of Gd 3+ , another MCU inhibitor, abolished this activity (Fig. 1b, Extended Data Fig. 1e ). Thus, MaMCU and FgMCU recapitulate key features of MCU and MCU is sufficient to form a pore.
We obtained diffracting crystals of MaMCU either by inserting rubredoxin into an NTD loop or with nanobody bound (Extended Data Fig. 2a , b, d and Extended Data Table 1 ). As crystal with nanobody diffracted X-rays better (to approximately 3.1 Å) and showed considerably better electron density in the transmembrane region, it was used for all structural interpretations. With 12 mercury sites introduced individually into the transmembrane region (Extended Data Fig. 2e ) and clear
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side chain densities (Extended Data Fig. 2f, g ), we could unambiguously register and build the side chains.
In the crystal, two crystallographically related dimers interact tightly, forming one MCU channel with a two-fold symmetry axis along the Ca 2+ -conducting pathway. MCU comprises three layers: a transmembrane domain, a coiled-coil, and an NTD, forming an elongated shape (Fig. 1c) . Notably, the oligomerization state, architecture, and single-subunit structure (including the selectivity filter configuration, packing mode between transmembrane helices, and overall fold) of MaMCU differed from the published pentameric structure of cMCU (Extended Data Fig. 3a, b) .
Transmembrane domain and ion conduction pore
The transmembrane domain has an approximately four-fold symmetry and the shape of a truncated pyramid (Fig. 1c) . The two transmembrane helices (TM1 and TM2) connect by a short loop. TM1 is located on the outside and TM2 lines the central ion conduction pore, consistent with the observation that TM1 of human MCU mediates the interaction with EMRE
22
. TM1 interacts loosely with TM2 of the same subunit and packs intimately against TM2 from a neighbouring subunit (Fig. 1c) , producing a sense of domain swapping in the transmembrane connectivity. In one pair of subunits, the connection between TM2 and the second helix of the coiled-coil is not well ordered, indicating flexibility.
The pore of MCU is narrow at the top. Notably, in contrast to the assumption that the signature motif DXXE lies within a loop, DXXE spans the first helical turn of TM2 with the strictly conserved Asp333 and Glu336 constituting the first two pore-lining residues (Fig. 2d) .
Asp333 is located at the intermembrane end of TM2 and is solvent exposed. Its side chain density was less resolved than those of other key residues. In the modelled configuration, the Asp333 side chain carboxylate does not directly point to the pore centre, potentially providing negative charge for Ca 2+ recruitment (Fig. 2e) . Alternatively, if Asp333 takes the most common rotamer position, which points into the pore, its carboxylate ring could coordinate a hydrated Ca
2+
, given a diameter of approximately 8 Å. One helical turn below Asp333 is Glu336, whose carboxylate group points to the pore centre (Fig. 2a, c) . We observed a strong density along the central axis, consistent with a bound ion surrounded by the carboxyl oxygens of Glu336 (Fig. 2a) . As the protein was purified and crystallized in the presence of 2 mM Ca 2+ and no other divalent ions, we assigned Ca 2+ at this location, which was further confirmed by a strong anomalous difference peak occupying the same location (Fig. 2b) . The diameter of the Glu336 carboxylate ring is approximately 5 Å, too small for hydrated Ca 2+ to go through. The observed Ca . We thus propose that Ca 2+ passes through a selectivity filter formed by the glutamate ring in a dehydrated form, similar to the direct coordination of Ca 2+ by four aspartate side chains in TRPV6
33
. Between the side chains of two neighbouring Glu336 is the indole ring of Trp332, which stabilizes the closely spaced carboxyl side chains of Glu336 through hydrogen bonds or anion-π interactions (Fig. 2c) . Trp332 also forms a close stacking interaction with Pro337 that is important for orientating Glu336 for Ca 2+ coordination. The intimately interacting Trp332, Glu336, and Pro337 are thus essential for proper configuration of the selectivity filter, consistent with their strict conservation across species.
One helical turn below Glu336 (and two below Asp333) is Tyr340. The aromatic side chain of Tyr340 is lined along the wall of the pore, forming a passage about 12 Å wide. Below the tyrosine, the pore is relatively wide open (Fig. 2f) , consistent with the high conductance of MCU. Near the matrix side, TM1 and TM2 of the same subunit make fewer direct contacts. Perhaps lipids fill in to seal the bottom of the channel, in line with weak extra density around this location.
Structure of the soluble domain
Within the mitochondrial matrix resides the soluble domain of MCU, comprised of an NTD, a coiled-coil, and a variable non-conserved C terminus. This domain is involved in MCU assembly, regulation of Article reSeArcH channel activity, and post-translational modification 14, 25, 34 . We determined the crystal structure of the soluble domain of MaMCU at 3.1 Å resolution (Extended Data Fig. 3c ), providing further support of its quaternary organization.
Notably, the globular NTD of MaMCU has the same structural fold as that of human MCU (root mean square deviation (r.m.s.d.) = 1.6 Å) despite there being no significant sequence similarity (Extended Data Fig. 3d ). Within the crystal lattice, the soluble domain forms a dimer-of-dimers configuration (Extended Data Fig. 2c ), matching well with the corresponding part of the whole MCU structure. Notably, a dimer interface of NTDs in MaMCU is the same as an interface of human NTD found in multiple crystal forms 14, 35 (Extended Data  Fig. 3e ). These observations support a conserved architecture from fungi to humans.
Single-particle electron microscopy of MCU
We used negative-stain electron microscopy to screen FgMCU and MaMCU exchanged into amphipols (A8-35 and PMAL-C8) or reconstituted into lipid nanodiscs. The negatively stained MCU proteins were monodisperse and showed two elongated densities extending parallel from the membrane region (Extended Data Fig. 4a ). Cryo-EM analysis was carried out on MaMCU in A8-35, FgMCU in PMAL-C8, and FgMCU in nanodiscs (Extended Data Figs. 4, 5) . The 2D averages showed the soluble domains organized with an approximate two-fold symmetry. Following 3D classification without symmetry (Extended Data Figs. 4, 5) , the 3D reconstructions consistently showed a dimer-of-dimers structure. 3D refinement with two-fold symmetry generated final maps at 5-7 Å resolution (Extended Data Table 2 ). The overall architectures of all three MCU complexes were essentially identical.
In the best cryo-EM 3D reconstructions using FgMCU in nanodiscs (Extended Data Fig. 5 ), all eight transmembrane helices were well resolved and arranged with a near four-fold symmetry (Fig. 3a) . The resolution was likely to be limited by the mobile transmembrane helices and flexible connection between the soluble and transmembrane domains. Focused 3D classification revealed different structures (Extended Data Fig. 5c ). One major class represented the conformation in the averaged cryo-EM map (conformation type 1; 19% of particles); another generated a 3D reconstruction showing less complete transmembrane helices but strong central densities, presumably contributed by hydrated ions or small molecules (conformation type 2; 21% of particles). These two classes were refined to 5 Å and 4.8 Å resolution, respectively, for the transmembrane domain (Extended Data  Fig. 6 ). The type 1 conformation superimposes well onto the structure model of MaMCU ( Fig. 3b and Extended Data Fig. 6g ). In the type 2 conformation, the lower halves of two opposing inner transmembrane helices appear to bend towards the centre (Extended Data Fig. 6g ), possibly representing a more closed conformation.
Stoichiometry and symmetry mismatch of MCU
To test whether our observed tetrameric organization represents the quaternary structure of MCU in the membrane, we performed site-directed disulfide bridge crosslinking. On the basis of the structure, we introduced a pair of cysteines at the protomer interface of the transmembrane domain on a cysteine-free background (Extended Data Fig. 7a ). In either detergent micelle or the isolated membrane, crosslinking under oxidizing conditions gave rise to a newly formed product with the expected size of a tetramer in a time-dependent manner (Extended Data Fig. 7b, c) . Furthermore, MaMCU crosslinked in the membrane migrated in the same way as untreated protein on size-exclusion chromatography (Extended Data Fig. 7d ). To evaluate whether the architecture of MCU is conserved in metazoan MCU, we made equivalent double cysteine mutations in MCU from mosquito, which possesses EMRE and MICU in the genome. Under oxidation conditions, the main cross-linked product migrated to the same tetramer position as that of MaMCU on SDS-PAGE (Extended Data Overall, MCU is organized as a dimer of dimers. The soluble domain shows two-fold symmetry, with each NTD directly contacting two neighbouring subunits through distinct interfaces (Fig. 4a ). By contrast, the transmembrane domain shows approximately four-fold rotational symmetry (Fig. 4b ). This symmetry mismatch is evident from the slice views of the cryo-EM map ( Fig. 3a) and is illustrated by markers on each domain in the crystal structure (Extended Data Fig. 7g ). Superimposing subunits A and C with neighbouring subunits B and D revealed how the symmetry mismatch might be reconciled (Fig. 4c) . First, the coiled-coil domain swings approximately 8° around its end near the NTD. This movement propagates through a long distance to the top of the transmembrane domain (about 85 Å away), resulting in a large displacement of the transmembrane domain. Second, the junction between the transmembrane domain and the coiled-coil is flexible and accommodates a roughly 20° bend right after the end of the coiled-coil, moving the transmembrane domain farther away. As a result, subunits A and C adopt a substantially different conformation from subunits B and D, even though each individual domain superimposes well. Both ends of the coiled-coil are likely to function as joints, providing flexibility for different relative orientations.
Functional studies of transmembrane domain
To validate the structural model and assess the functional role of residues in the transmembrane domain, we performed a systematic alanine scan. Consistent with the structural observations, single point mutations that substantially impaired uptake activity were mostly concentrated on the pore-facing side of TM2, with a helical periodic distribution pattern (Fig. 5a, b) . The strictly conserved Trp332, Pro337, and Glu336, which are essential for proper configuration of the selectivity filter, were indispensable for uptake. Substitution of Tyr340, which sits Article reSeArcH directly below the filter, substantially impaired uptake and proper protein folding, indicating an important structural role while complicating specific functional interpretation. The residue on TM1 that showed the most pronounced effect on uptake activity was Trp317, whose side chain constitutes a primary contact point between TM1 and TM2. Mutating Phe326 or Gly331 of the TM1-TM2 linker also impaired Ca 2+ uptake, probably owing to their effect on the linker conformation and thus the configuration of the pore entrance.
We examined the effect of the mutations on the sensitivity of MCU to ruthenium red by testing residues near the intermembrane surface. Substitution of D333A had the most marked effect and substantially reduced sensitivity to ruthenium red (Extended Data Fig. 8 ), consistent with an equivalent mutation of the human MCU 36 . Ser259 of the human MCU, another residue involved in ruthenium red sensitivity, is not conserved in MaMCU or FgMCU 10,11 . Perhaps positively charged ruthenium red interacts with negatively charged Asp333 near the entrance of the pore and blocks the channel, competing with the Ca 2+ -binding site. This would explain why ruthenium red inhibited inward but not outward current of MCU 6 . Together, our mutagenesis studies are fully compatible with the structure, providing insights into MCU function.
Discussion
Our X-ray and electron microscopy structures, together with membrane cross-linking and functional experiments, have revealed a conserved dimer-of-dimers architecture of MCU with physiological relevance. The marked difference between our MCU and the cMCU structures might be related to the approaches used, as the cMCU sample preparation involved the relatively harsh detergent Fos-choline-14 and inclusion bodies, and the oligomerization state of cMCU was inferred from an 18 Å-resolution negative-stain electron microscopy reconstruction 28 . The channel domain of MCU represents a previously undescribed architecture of ion channels. Compared with voltage-gated ion channels (VGICs), MCU has a roughly inverted shape resembling a truncated pyramid. Moreover, the selectivity filter of MCU is formed by side chains on TM2, as opposed to a reentry loop lining the pore for VGICs [37] [38] [39] [40] [41] [42] [43] [44] 40 . During the gating cycle of iGluRs, the ligand-binding domain undergoes substantial re-organization and transitions between two-fold and four-fold symmetry 46 . By analogy, a similar reorganization in the NTD could modulate MCU channel activity by switching subunits A and C or B and D between alternate conformations, thereby altering the packing or conformation of the transmembrane helices. In the crystal structure of MaMCU, immediately below the selectivity filter, Tyr340 interacts with residues on the neighbouring subunit, orienting its side chain along the pore. Notably, the cryo-EM map of FgMCU shows density in the pore that could potentially result from one pair of Tyr340 side chains pointing into the pore. Although higher resolution is needed for a definitive assignment, an intriguing possibility is that altered transmembrane packing may weaken the interactions of Tyr340 with nearby transmembrane helices to facilitate a rotamer switch of one pair of tyrosines to control Ca 2+ flow through the pore. Alternatively, the rearrangement of NTDs could potentially lead to bending of transmembrane helices to constrict the pore, as suggested by two possible conformations in the cryo-EM map.
In summary, our structures and biochemical studies establish the stoichiometry and architecture of MCU and provide important insights into Ca 2+ coordination and permeation. In the future, structures at higher resolutions, in various states, and in complex with regulatory components will be needed for a detailed mechanistic understanding of Ca 2+ selectivity and channel gating.
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MEthodS
Expression and purification. The coding sequence of Metarhizium acridum MCU without mitochondrial signal peptide (residues 62-484) was codon optimized and cloned into a modified pNGFP-BC plasmid with an N-terminal His-tag, GFPuv, and a 3C protease cleavage site. Based on limited proteolysis and secondary structure prediction, the unstructured N-and C-termini and a disordered loop at the NTD were removed. A construct lacking residues [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] , and 427-484 yielded weakly diffracting crystals. To promote better crystal growth, Clostridium pasteurianum rubredoxin was fused into a loop between S213 and G214 at the NTD, and two point mutations (H327W and M330F) were introduced. This construct, named MaMCU-Rub, was fully functional and produced improved crystals. To prepare MaMCU soluble domain, the N-terminal and C-terminal parts of the protein were directly fused together by deleting the transmembrane (TM) domain (Δ295-386). A disordered long loop in the NTD (residues 193-222) was further truncated. The final construct was named MaMCUsd and cloned into pNGFP-BC. Similarly, the coding sequence of Fusarium graminearum MCU was codon optimized and cloned into pNGFP-BC. The mitochondrial signal peptide and disordered N-and C termini were truncated (Δ1-120 and Δ448-480). Two disordered and non-conserved loops (residues 148-159 and 215-241) within the NTD were also removed.
To prepare the MaMCU protein sample, the transformed E. coli BL21 (DE3) cells were grown at 37 °C until the OD 600 reached 0.8-1.0 and the temperature was lowered to 20 °C. Overexpression was induced by 0.2 mM isopropyl β-D-thiogalactoside and the cells were harvested 18 h post induction. Cells were lysed by sonication in a buffer containing 50 mM Tris, pH 8.0, 150 mM NaCl, 2 mM CaCl 2 , and protease inhibitor cocktail. Membrane proteins were extracted by incubating the lysate or the isolated membrane with 2% n-dodecyl-β-D-maltoside (DDM, Anatrace) at 4 °C for 2 h. After removal of the insoluble fractions, the supernatant was incubated with prewashed cobalt resin at 4 °C for 2 h. After washing the resin with five column volumes (CV) of buffer A containing 20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM CaCl 2 , and 0.05% DDM supplemented with 10 mM imidazole and 10 CV of buffer A supplemented with 20 mM imidazole, the resin was washed with buffer A and then incubated with 3C protease overnight to cleave the tag. MaMCU was further purified by gel filtration (Superdex 200 increase, GE healthcare) in buffer containing 20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM CaCl 2 , and 0.03% DDM. The peak fraction was collected and concentrated to 10-15 mg/ml for further use.
MaMCU-Rub was purified similarly with a few modifications. The cell pellets were suspended in lysis buffer containing 50 mM Tris, pH 8.0, 150 mM NaCl, 10 mM MgCl 2 , and protease inhibitor cocktail. After sonication, membrane proteins were extracted by 2% n-decyl-β-D-maltoside (Anatrace) at 4 °C for 2 h. The insoluble fractions were removed by centrifugation and the supernatant was incubated with prewashed cobalt resin at 4 °C for 2 h. The protein was purified by affinity chromatography using cobalt resin, released from the resin by 3C protease, and further purified by gel filtration (Superdex 200 increase, GE Healthcare) in buffer containing 10 mM HEPES, pH 7.5, 150 mM NaCl, 10 mM MgCl 2 , and 0.1% n-undecyl-β-D-maltoside (Anatrace). The peak fraction was collected and concentrated to 10 mg/ml for crystallization. Expression of selenomethioninelabelled MaMCU-Rub protein was achieved by following a published protocol 47 . The protein was purified in the same manner as the unlabelled protein. To produce mercury-labelled MaMCU-Rub protein, cysteine point mutations were introduced by two-step PCR 48 , and the protein was incubated with 2.5 mM thimerosal at room temperature for 2 h before further purification by gel filtration.
The soluble matrix domain of MaMCU, MaMCUsd, was expressed and purified following the same protocol as described above, except that surface reductive methylation was performed after elution from the affinity column 49 and the gel filtration buffer did not contain any detergent. The peak fraction was collected and concentrated to 10 mg/ml for crystallization trials.
FgMCU proteins were purified following the same protocol above for MaMCU. The final gel filtration buffer contained 20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM CaCl 2 , and 0.03% DDM. Nanobody selection and purification. Nanobodies were obtained from screening immunized and synthetic libraries following published protocols 50, 51 . Phage display libraries that contain about 10 8 transformants were used to screen specific binders to MCUs. After four rounds of selection, specific binders against MCUs were clearly enriched. The enriched clones were transferred into a yeast display system and further screened against MaMCU for three additional rounds following published protocols 52 . Nanobodies that specifically recognize MaMCU were cloned into expression vector pMES4 with His tag. Five nanobodies were expressed in E. coli BL21 (DE3) and purified according to the standard procedure using cobalt resin. Crystallization. Crystallization trials were performed using the hanging-drop vapour-diffusion method at 20 °C. MaMCU-Rub protein was mixed at a 1:0.8 ratio with reservoir solution containing 100 mM HEPES, 7.5, 0.1 M MgCl 2 , and 14% PEG 2000 MME. The crystals grew to full size in one to two weeks. Crystals were incubated in a cryoprotectant solution with the addition of 20% glycerol, and were flash-frozen in liquid nitrogen. MaMCU in complex with nanobody was prepared by mixing both components at a 1:1 ratio. The crystals were grown by vapour-diffusion in the presence of 15% PEG 2050, 200 mM (NH 4 ) 2 SO 4 , and 100 mM Na-cacodylate, pH 6.0. The crystals grew to full size in about one week. The crystals were cryo-protected by the addition of 20% glycerol and flash frozen in liquid nitrogen. The MaMCUsd crystals were grown using the same method as described above. Plate-like crystals were grown in 0.1 M glycine, pH 9.3, 15.5% PEG 4000, and 0.6 M NaNO 3 . The crystals were cryo-protected by adding 24% ethylene glycol into the crystallization buffer, and were then flash-frozen in liquid nitrogen. Data collection and structural determination. The diffraction data were collected at beamlines 24ID-C/E, 23ID-B/D and 17ID of the Advanced Photon Source, 5.0.2 of the Advanced Light Source, and 12-2 of the Stanford Synchrotron Radiation Lightsource. Native data set for MaMCU-Rub, and MaMCUsd was collected based on a single crystal and native data set for MaMCU was merged from three crystals. The diffraction data were processed using XDS 53 or HKL2000 54 . The selenomethionine anomalous data were merged from multiple crystals. The data were integrated using XDS 53 as implemented in RAPD (https://github.com/RAPD/ RAPD). The mercury anomalous data were collected on multiple crystals or multiple spots on the same crystals and were processed by XDS 53 or HKL2000 54 . The initial phase for MaMCUsd was obtained using a 10 Å EM map as a search model using Phaser 55 , and the phase was gradually extended through NCS averaging to a 3.1 Å resolution by RESOLVE through Phenix 56 . The map was of sufficient quality to trace secondary structures. The initial model was built using AutoBuild in Phenix. The model was manually rebuilt in Coot 57 and refined by Phenix 56 in an iterative manner. The initial single wavelength anomalous dispersion (SAD) phasing for MaMCU-Rub (crystal form I) was obtained from either selenomethionine anomalous data or mercury anomalous data using SHELX C/D/E in HKL2Map 58 . In addition, an MR-SAD (combination of molecular replacement and single wavelength anomalous dispersion) protocol was carried out for the selenomethionine anomalous data and mercury anomalous data based on a molecular replacement (MR) solution with the soluble domain model (MaMCUsd) as the search model. SAD and MR-SAD maps allowed tracing and registering the soluble domain with the aid of the MaMCUsd model. For the TM domain, initially ideal poly-alanine helices were manually placed into the SAD and MR-SAD maps, guided by the EM map. To assist assignment of the helix register, we made single cysteine mutants for each residue on the TM helices. The accessibility of cysteine for the mercury labelling was assessed by 5,5′-Dithiobis(2-nitrobenzoic acid) on the purified protein. For each mutant, the MR solution was obtained by Phaser 55 . The Hg sites were identified by Phaser EP in Phenix 56 and confirmed by anomalous difference maps. The register of the TM helices were aided by 12 Hg markers on two TM helices, one Hg marker on the linker connecting TM1 and TM2, as well as a selenomethione marker on TM2. For MaMCU in complex with the nanobody (crystal form II), the combined and scaled data from 3 crystals was anisotropically truncated using UCLA Diffraction Anisotropy Server. The data (3.9 Å × 3.1 Å × 3.3 Å along a*, b*, and c* axes, respectively) was used for refinement. The molecular replacement solution was found using MaMCU-Rub as a search model by Phaser 55 . The model was iteratively refined and rebuilt in Phenix 56 , Buster 59 and Coot 57 . This final model was used for all structural interpretation on MaMCU. Structural quality was reported by MolProbity 60 and structural renderings were prepared using PyMOL (Schrödinger, LLC). Ion-conducting pore radius was calculated by HOLE 61 . Cryo-EM sample preparation. To reconstitute the MCU in amphipol, purified proteins after gel filtration were mixed with amphipol A8-35 (Anatrace) or PMAL-C8 (Anatrace) at a mass ratio of 1:3 for 3 h on ice. To prepare the MCU in nanodiscs, purified proteins were mixed with an equal molar ratio of the scaffold protein MSP1D1 in the presence of an 8 mM lipid mixture that contained 3:1 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine (POPC, Avanti) and cardiolipin (Avanti) for 2 h on ice. The protein samples with amphipol and nanodiscs were incubated with Bio-beads at 4 °C overnight to remove detergents and were further purified by gel filtration in a buffer containing 150 mM NaCl, 10 mM Tris, pH 8.0, and 2 mM CaCl 2 . The peak fraction was collected for EM analysis. Cell-based uptake assay. The MCU and a membrane-tethering calcium sensor Lck-GCaMP2 30,62 were co-expressed using a pETDuet1 vector. The transformed E. coli strain BL21(DE3) was induced as described above. A 3 ml cell culture was centrifuged and washed twice with 3 ml UAB buffer (100 mM KCl, 50 mM Tris, pH 7.5, 1 mM MgCl 2 ), and then diluted to an OD600 of 1.0 for an uptake assay. A large negative membrane potential across the E. coli plasma membrane 63 drives Ca 2+ uptake. The assays were carried out using Greiner black polystyrene flat-bottom 96-well plates (Sigma-Aldrich). For each assay reaction, 50 μM or 0.5 mM calcium was added into 100 μl cells and immediately mixed to initiate the uptake. For ruthenium red inhibition experiments, 0.5-2 μM ruthenium red (Sigma-Aldrich) was mixed with cells before uptake assays. All experiments were performed at room temperature and repeated at least four times. Data were recorded on an infinite M1000Pro plate reader and processed using Tecan i-contro software. Fluorescent signals were measured every 5-10 s with the excitation set at 485 nm and emission at 510 nm. Ca 2+ uptake activity is quantified as a linear fit of the fluorescence signal during the first 20 s after the addition of calcium. To evaluate the expression level of the MCU mutants, MCU mutant constructs were cloned into pNGFP-BC. Proteins were expressed in 3 ml LB culture under the identical condition as for the functional assay. Solubilized proteins were analysed by SDS-PAGE and MCU-GFP fusion protein was visualized by in gel fluorescence using a Bio-Rad imaging system with excitation at 302 nm and emission at 440 nm. Liposome-based flux assay. Liposome was reconstituted according to a published protocol 64 . Purified MCU proteins were mixed with E. coli polar lipids (Avanti) at a 1:80 ratio in the presence of reconstitution buffer (150 mM NaCl, 10 mM HEPES, pH 7.5, 5 mM EDTA) plus 0.12% (w/v) Triton-X100. Detergents were removed by overnight incubation with Bio-beads. After extrusion through a 0.4 μm membrane, proteoliposome was pelleted by ultracentrifugation at 100,000 g for 1 h. The proteoliposome was washed twice with ice-cold FAB buffer that contained 150 mM NMDG, 10 mM HEPES, pH 7.5, 5 mM EDTA and 2 μM ACMA, and then resuspended in the same buffer to a final lipid concentration of 100 mg/ml. The flux assay was performed following published protocols 31, 65, 66 in a 96-well format. A total of 2 μl of proteoliposomes were diluted into 100 μl of FAB. After 150 s, 1 μM carbonyl cyanide m-chlorophenyl hydrazone (CCCP, Sigma-Aldrich) was added to initiate Na + flux. A total of 20 nM sodium ionophore monensin (Sigma-Aldrich) was added near the end of the experiments to release Na + from the liposomes. For Gd 3+ blockage experiments, 0.3 mM GdCl 3 was added to the FAB buffer before flux assays. Data collected on an infinite M1000Pro plate reader were processed using Tecan i-contro software. Fluorescent signals were measured every 15 s (excitation: 410 nm and emission: 490 nm). Cysteine crosslinking. Double cysteine substitutions were introduced in a cysteine-free version of MaMCU by two-step PCR 48 . The mutants were expressed in the same manner as the WT protein. For crosslinking in detergent solution, 1 mg/ml purified protein in DDM buffer (20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM CaCl 2 , 0.03% DDM) was incubated with 0.1 mM of Cu(II) (1,10-phenantroline) 3 at 4 °C. For crosslinking in membrane, the membrane fraction containing overexpressed His-tagged protein was prepared and incubated with 0.3 mM of Cu(II) (1,10-phenantroline) 3 at 4 °C. The reactions were stopped at different time points by the addition of EDTA to a final concentration of 50 mM, and the reaction products were analysed by SDS-PAGE. For western blot analysis, the proteins were transferred from a gel to a PVDF membrane and probed with mouse anti-pentaHis antibody (Qiagen), followed by detection with donkey anti-mouse IR680 secondary antibody (LI-COR Biosciences). Blots were visualized and analysed using a LI-COR Odyssey system. Double cysteine substitutions of mosquito MCU was expressed and purified in DDM with 0.01% cholesteryl hemisuccinate similarly to MaMCU. The crosslinking was performed in DDM buffer with 0.01% cholesteryl hemisuccinate in a similar manner to MaMCU. Electron microscopy data acquisition. Negatively stained specimens were prepared following an established protocol with minor modifications 67 . Specifically, 2.5 μl of purified MCU was applied to glow-discharged copper EM grids covered with a thin layer of continuous carbon film, and the grids were stained with 2.5% (w/v) uranyl formate. These grids were imaged on a Tecnai T12 electron microscope (FEI) operated at 120 kV at a nominal magnification of 67,000x using a 4k × 4k CCD camera (UltraScan 4000, Gatan), corresponding to a calibrated pixel size of 1.68 Å on the specimen level. For cryo-EM of FgMCU in PMAL-C8 and nanodiscs, 4 μl of a 5 mg/mL sample containing 0.3 mM fluorinated Fos-Choline-8 (Anatrace) was applied to a glow-discharged Quantifoil holey carbon grid (1.2/1.3, 400 mesh), and blotted for 3 s with ~92% humidity before plunge-freezing in liquid ethane using a Cryoplunge 3 System (CP3, Gatan). For cryo-EM of MaMCU in A8-35, a 2.5 μl sample at a concentration of 2 mg/ml applied to a grid was similarly blotted and plunge-frozen using a CP3. The cryo-EM data were recorded on a 300 kV Polara electron microscope (FEI) at Harvard Medical School, and a 200 kV Talos Arctica and a 300 kV Titan Krios electron microscope (FEI) at the University of Massachusetts Medical School. All cryo-EM movies were recorded with a K2 Summit direct electron detector (Gatan) in super-resolution counting mode using UCSFImage4 68 or SerialEM 69 . The details of the EM data collection parameters are listed in Extended Data Table 1 . EM image processing. The EM data were processed as previously described 70 . Negative-stain EM images were binned over 2 × 2 pixels for further processing, yielding a pixel size of 3.36 Å. Dose-fractionated super-resolution movies collected using the K2 Summit direct electron detector were binned over 2 × 2 pixels, and then subjected to motion correction using the program MotionCor2 71 . A sum of all frames of each image stack was calculated following a dose-weighting scheme, and used for all image-processing steps except for defocus determination. The program CTFFIND4
72 was used to calculate defocus values of the summed images from all movie frames without dose weighting. Particle picking was performed using a semi-automated procedure with SAMUEL and SamViewer 73 . 2D classification of selected particle images was carried out by SPIDER (samclasscas.py) or by RELION 74, 75 . Initial 3D models were generated with 2D class averages by SPIDER 3D projection matching refinement (samrefine.py), starting from a cylindrical density mimicking the size and shape of the MCU. 3D classification and refinement were carried out using "relion_refine_mpi" in RELION. The masked 3D classification focusing on the TM domain of FgMCU in nanodiscs with residual signal subtraction was performed following a previously described procedure 76 . The first round of 3D classification of all cryo-EM data sets was carried out without symmetry, which was followed by further 3D classification and refinement with two-fold symmetry. All refinements followed the gold-standard procedure, in which two half data sets were refined independently. The overall resolutions were estimated based on the gold-standard criterion of Fourier shell correlation (FSC) = 0.143. Local resolution variations were estimated from two half data maps using ResMap 77 . The amplitude information of the final maps were corrected by applying a negative B-factor using the program bfactor.exe 78 . To compare the crystal structure with the cryo-EM maps, the atomic model was fitted into the cryo-EM maps as a rigid body using the function of "Fit in Map" in UCSF Chimera For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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